Bain and Cinven set out to conquer Stada


The private equity firms Bain Capital and Cinven have teamed up on the German pharmaceutical group Stada, with the launch of an increased bid on 10 July following a first failed attempt at EUR5.3bn. The two firms are offering EUR66.25 per share, up from EUR66 previously, with a reduced acceptance rate of 63%, Stada has announced, adding that it consents to the new offer, as it had done previously.The previous offer from Bain and Cinven, launched in April, was approved by investors representing only 65.52% of capital in the generic medication manufacturer, though the required threshold is 67.5%.